Insight Molecular Diagnostics Share Holder Equity 2014-2025 | IMDX
Insight Molecular Diagnostics share holder equity from 2014 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
| Insight Molecular Diagnostics Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $-12 |
| 2023 | $20 |
| 2022 | $34 |
| 2021 | $65 |
| 2020 | $33 |
| 2019 | $31 |
| 2018 | $3 |
| 2017 | $4 |
| 2016 | $10 |
| 2015 | $10 |
| 2014 | $-1 |
| 2013 | $4 |
| Insight Molecular Diagnostics Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-06-30 | $1 |
| 2025-03-31 | $10 |
| 2024-12-31 | $-12 |
| 2024-09-30 | $10 |
| 2024-06-30 | $23 |
| 2024-03-31 | $12 |
| 2023-12-31 | $20 |
| 2023-09-30 | $38 |
| 2023-06-30 | $44 |
| 2023-03-31 | $38 |
| 2022-12-31 | $34 |
| 2022-09-30 | $77 |
| 2022-06-30 | $83 |
| 2022-03-31 | $57 |
| 2021-12-31 | $65 |
| 2021-09-30 | $99 |
| 2021-06-30 | $103 |
| 2021-03-31 | $107 |
| 2020-12-31 | $33 |
| 2020-09-30 | $35 |
| 2020-06-30 | $40 |
| 2020-03-31 | $37 |
| 2019-12-31 | $31 |
| 2019-09-30 | $29 |
| 2019-06-30 | $34 |
| 2019-03-31 | $38 |
| 2018-12-31 | $3 |
| 2018-09-30 | $8 |
| 2018-06-30 | $7 |
| 2018-03-31 | $9 |
| 2017-12-31 | $4 |
| 2017-09-30 | $8 |
| 2017-06-30 | $6 |
| 2017-03-31 | $9 |
| 2016-12-31 | $10 |
| 2016-09-30 | $13 |
| 2016-06-30 | $4 |
| 2016-03-31 | $7 |
| 2015-12-31 | $10 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $-1 |
| 2013-12-31 | $4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.074B | $0.002B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.466B | 59.12 |
| Tempus AI (TEM) | United States | $12.696B | 0.00 |
| Doximity (DOCS) | United States | $11.914B | 53.01 |
| Hims & Hers Health (HIMS) | United States | $9.534B | 78.11 |
| IRhythm Technologies (IRTC) | United States | $5.093B | 0.00 |
| Hinge Health (HNGE) | United States | $4.374B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.663B | 39.16 |
| Privia Health (PRVA) | United States | $2.603B | 192.82 |
| Heartflow (HTFL) | $2.489B | 0.00 | |
| Enovis (ENOV) | United States | $1.740B | 9.20 |
| Phreesia (PHR) | United States | $1.681B | 0.00 |
| 10x Genomics (TXG) | United States | $1.669B | 0.00 |
| Omnicell (OMCL) | United States | $1.466B | 28.24 |
| Schrodinger (SDGR) | United States | $1.428B | 0.00 |
| Azenta (AZTA) | United States | $1.388B | 60.58 |
| Clover Health Investments (CLOV) | United States | $1.292B | 0.00 |
| Claritev (CTEV) | United States | $1.115B | 0.00 |
| Evolent Health (EVH) | United States | $1.057B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.660B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.568B | 0.00 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Butterfly Network (BFLY) | United States | $0.347B | 0.00 |
| Carlsmed (CARL) | $0.333B | 0.00 | |
| TruBridge (TBRG) | United States | $0.293B | 51.40 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.237B | 0.00 |
| Outset Medical (OM) | United States | $0.237B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.211B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.182B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.137B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.119B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 5.23 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.086B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |